Exploration Capital, LLC's Form 4 filing
Fresh Tracks Therapeutics, Inc. (FRTX) · filed Apr 1, 2024
- Accession no.
- 0001213900-24-028916
- Filed
- Apr 1, 2024
- Trade date
- Mar 27-Apr 1, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $49.1K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Exploration Capital, LLCCIK 0002003514 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | Common Stock | PPurchaseAcquired | +51,634 | $0.90 | +$46,470.6 | 1,015,773 | Direct | |
| Mar 28, 2024 | Common Stock | PPurchaseAcquired | +2,586 | $0.90 | +$2,327.4 | 1,018,359 | Direct | |
| Apr 1, 2024 | Common Stock | PPurchaseAcquired | +354 | $0.89 | +$315.06 | 1,018,713 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.